VIRIOM
Viriom Inc. is a development and commercial stage biotech company developing novel and affordable medicines against life threatening infections such as HIV and HBV. The company has an exclusive worldwide license to its phase 3 and commercial stage lead compounds (Elpida/elsulfavirine and VM1500A) from Hoffmann-La Roche and has developed proprietary drug candidates VM2500, VM3500 LAI formulations and combinations with cell, vaccine and antibody drugs for treatment, prophylaxis and cure of HIV. Viriom makes a breakthrough in treating, preventing and curing HIV and chronic HBV infections worldwide.
VIRIOM
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2009-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.viriom.com
Total Employee:
51+
Status:
Active
Contact:
+1-858-7944860
Email Addresses:
[email protected]
Total Funding:
35.41 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Google Apps For Business Microsoft Azure DNS AJAX Libraries API
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
EnBiotix
EnBiotix advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Investors List
Pharmstandard
Pharmstandard investment in Convertible Note - Viriom
Torrey Pines Investment
Torrey Pines Investment investment in Convertible Note - Viriom
ChemRar Ltd
ChemRar Ltd investment in Convertible Note - Viriom
Skolkovo Foundation
Skolkovo Foundation investment in Convertible Note - Viriom
Torrey Pines Investment
Torrey Pines Investment investment in Convertible Note - Viriom
Torrey Pines Investment
Torrey Pines Investment investment in Convertible Note - Viriom
MIT RF
MIT RF investment in Seed Round - Viriom
ChemRar Ventures
ChemRar Ventures investment in Seed Round - Viriom
MIT RF
MIT RF investment in Non Equity Assistance - Viriom
ChemRar Ventures
ChemRar Ventures investment in Seed Round - Viriom
Official Site Inspections
http://www.viriom.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
